Transarterial Radioembolization for Hepatocellular Carcinoma in Korea: Current Clinical Practices, Facility Requirements, and Patient Selection
Before initiating Yttrium-90 (90Y) radioembolization, both the interventional radiology and nuclear medicine departments must prepare facilities for radionuclide handling, implement appropriate radiation protection and monitoring measures, and ensure that all medical personnel possess the require...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Society of Radiology
2025-07-01
|
| Series: | Journal of the Korean Society of Radiology |
| Subjects: | |
| Online Access: | https://doi.org/10.3348/jksr.2025.0049 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Before initiating Yttrium-90 (90Y) radioembolization, both the interventional radiology and
nuclear medicine departments must prepare facilities for radionuclide handling, implement
appropriate radiation protection and monitoring measures, and ensure that all medical personnel
possess the required government-issued certification. According to current guidelines,
transarterial radioembolization is recommended as an alternative treatment option
for patients with a single hepatocellular carcinoma measuring ≤8 cm and classified as stage
I, II, or III according to the modified Union for International Cancer Control staging system.
However, these indications may be adjusted based on the institution’s medical clinical setting
and resources. Given the potential for irreversible tissue damage from 90Y, treatment efficacy
and safety must be assessed through planning angiography and either planar imaging
or SPECT-CT using 99mTc-macroaggregated albumin. |
|---|---|
| ISSN: | 2951-0805 |